Circulating Heme Oxygenase-1 and Complement Activation in Transplant-Associated Thrombotic Microangiopathy
Open Access
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 25 (8) , 1486-1491
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantationAnnals of Hematology, 2017
- Transplant-associated thrombotic microangiopathy: opening Pandora’s boxBone Marrow Transplantation, 2017
- Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?Bone Marrow Transplantation, 2016
- Heme Oxygenases in Cardiovascular Health and DiseasePhysiological Reviews, 2016
- The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathyBlood, 2016
- Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathyBlood, 2013
- Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic SyndromeNew England Journal of Medicine, 2013
- Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchangeBone Marrow Transplantation, 2009
- Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?Bone Marrow Transplantation, 2007
- Transplantation-associated thrombotic microangiopathy: twenty-two years laterBone Marrow Transplantation, 2002